LGI 1 IgG Associated Autoimmune Encephalitis Natural History Study

Overview

About this study

The purpose of this study is to perform retrospective data collection for a natural history study of LGI1 IgG seropositive patients seen at Mayo Clinic sites or Mayo Clinic health system. Also, to identify new LGI1 IgG seropositive patients seen at Mayo Clinic sites or Mayo Clinic health system through the clinical lab for prospective data collection and evaluation for potential clinical trial enrollment.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

LGI1 IgG seropositive.

Exclusion Criteria:

< 18 years of age.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 1/13/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Divyanshu Dubey, M.B.B.S.	Open for enrollment	Contact information: Holly Morrison (507) 266-4758 Morrison.Holly@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Divyanshu Dubey, M.B.B.S.

Open for enrollment

Contact information:

Holly Morrison

(507) 266-4758

Morrison.Holly@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials